- Home
- INAB vs CELZ Comparison
INAB vs CELZ Comparison
Compare INAB & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- CELZ
- Stock Information
- Founded
- INAB 2016
- CELZ 1998
- Country
- INAB United States
- CELZ United States
- Employees
- INAB N/A
- CELZ N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- INAB Health Care
- CELZ Health Care
- Exchange
- INAB Nasdaq
- CELZ Nasdaq
- Market Cap
- INAB 8.7M
- CELZ 7.4M
- IPO Year
- INAB 2021
- CELZ N/A
- Fundamental
- Price
- INAB $2.10
- CELZ $3.50
- Analyst Decision
- INAB Strong Buy
- CELZ
- Analyst Count
- INAB 2
- CELZ 0
- Target Price
- INAB $108.00
- CELZ N/A
- AVG Volume (30 Days)
- INAB 52.4K
- CELZ 48.7K
- Earning Date
- INAB 11-11-2025
- CELZ 11-07-2025
- Dividend Yield
- INAB N/A
- CELZ N/A
- EPS Growth
- INAB N/A
- CELZ N/A
- EPS
- INAB N/A
- CELZ N/A
- Revenue
- INAB N/A
- CELZ $6,000.00
- Revenue This Year
- INAB N/A
- CELZ N/A
- Revenue Next Year
- INAB N/A
- CELZ N/A
- P/E Ratio
- INAB N/A
- CELZ N/A
- Revenue Growth
- INAB N/A
- CELZ N/A
- 52 Week Low
- INAB $1.91
- CELZ $1.69
- 52 Week High
- INAB $16.70
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- INAB 43.89
- CELZ 63.17
- Support Level
- INAB $1.91
- CELZ $3.16
- Resistance Level
- INAB $2.26
- CELZ $3.60
- Average True Range (ATR)
- INAB 0.11
- CELZ 0.14
- MACD
- INAB -0.01
- CELZ 0.01
- Stochastic Oscillator
- INAB 48.72
- CELZ 80.39
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.